The global metabolomics biomarker market is anticipated to grow at a considerable CAGR of around 12% during the forecast. Metabolomics is an emerging field of ‘‘omics’’ research that focuses on the high-throughput characterization of small molecule metabolites in biological matrices. The approaches of metabolomics are applied in the biological systems, including humans, plants, and microorganisms.
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/metabolomics-biomarker-market
The advancement of metabolomics technologies provides improved diagnosis, more appropriate therapeutic targets, and allows a more accurate prognosis of disease development. The recent development of instrumental systems such as mass spectrometry, ultra-performance liquid chromatography, high-resolution NMR spectroscopy, and more advanced bioinformatics and analytical technologies has facilitated more wide-ranging exposure of the metabolome. Therefore, innovative development in informatics and analytical technologies is driving the market growth.
Market coverage
- The market number available for – 2019-2026
- Base year- 2019
- Forecast period- 2020-2026
- Segment covered-
o By Application
o By Technology
o By End-User
- Regions covered-
o North America
o Europe
o Asia-Pacific
o Rest of the world
- Competitive landscape- BG Medicine Inc., Biomark Diagnostics Inc., Evotec A.G., Merck KGaA, Metabolomic Diagnostics Ltd., Stemina Biomarker Discovery, Inc., and Thermo Fisher Scientific Inc.
Key Questions Addressed By the Report
- What is the market growth rate?
- Which segment and region dominate the market in the base year?
- Which segment and region will project the fastest growth in the market?
- How has COVID-19 impacted the market?
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
- Who is the leader in the market?
- How are players addressing challenges to sustain growth?
- Where is the investment opportunity?
Global Metabolomics Biomarker Market Report Segment
By Application
- Toxicological Studies
- Drug Testing
- Diagnosis
By Technology
- Chromatography
- Nuclear Magnetic Resonance (NMR)
- Mass Spectrometry
- Other
By End-User
- Hospitals
- Diagnostic Labs & Research Centers
A full report of Metabolomics Biomarker Market is available at: https://www.omrglobal.com/industry-reports/metabolomics-biomarker-market
Metabolomics Biomarker Market– Segment by Region
North America
- United States
- Canada
Europe
- Germany
- United Kingdom
- France
- Spain
- Italy
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Rest of Asia-Pacific
Rest of the World
- Middle East & Africa
- Latin America
Company Profiles
- AB Sciex LLC
- Agilent Technologies, Inc.
- BG Medicine Inc.
- Biocrates Life Sciences AG
- Biomark Diagnostics Inc.
- Bruker Corp.
- Chenomx Inc.
- Creative Proteomics
- Evotec A.G.
- Human Metabolome Technologies America, Inc.
- Merck KGaA
Reasons to Buying From us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research
